MAR 17, 2014 12:00 AM PDT

Early warnings signs of dementia and Alzheimer's disease

WRITTEN BY: Jen Ellis
If you could take a test and find out that you are going to develop Alzheimer's disease, would you want to know? Would your opinion change if the test were only 90% effective? This is a choice that people may have the ability to make in the not too distant future, based on recent research from Georgetown University.

The research team has developed a blood test that analyzes ten specific lipids in the bloodstream to assess early warnings signs of dementia and Alzheimer's disease. These lipids undergo changes as part of the breakdown process of brain cell membranes, and thus may serve as useful markers for the onset of dementia.

The lipid connection was produced from samples of blood taken from over 500 volunteers aged 70 and older. These patients were observed over a five-year period for signs of developing dementia, and the earliest observations of dementia yielded the ten test lipids as potential markers.

With this observation, researchers tested the remaining volunteers for correlations over time between the lipid markers and the development of dementia or Alzheimer's. The results were that in 90% of the cases, the lipid markers correctly assessed the future state of the patient within a two or three year timeframe. A summary of this work was published recently in Nature Medicine.

The goal of the research team is to validate the lipid test over a larger population, and eventually offer this test commercially. The goal is not completely related to money-the team believes that research for a cure can be advanced if a population is identified that would be ready and willing to consider clinical trials of experimental therapies. If the disease has progressed beyond a certain point, intervention may be futile. Analogous to cancer treatments, the sooner Alzheimer's or dementia is detected, the more likely it is that an effective treatment can be found.

A test of this nature would need to mimic cancer treatments in another way-it would be important to set up counseling so that people can understand the risks involved and how to cope with the potential results they may get. It is also very important that people be presented with the choice of whether to take the test or not.

Quite a number of ethical concerns and other practical issues would have to be dealt with before this test could be commercially offered. For example, what are the insurance implications? An insurance company would be unlikely to be able to mandate such a test, but if you choose to take it, do they have a right to know the results? Would an insurance company have the right to alter your coverage based on your new assessment of risk?

Alzheimer's is a devastating disease, and anything that can truly advance a cure is a worthwhile development. Hopefully, the lipid test is refined and can indeed be used to expedite a cure-but it remains extremely important that individuals have the choice of participating in the test, or letting nature take it's course, so to speak.

What would you do? You still have a few years to make up your mind.
About the Author
You May Also Like
MAR 16, 2021
Clinical & Molecular DX
A Blood Test for Predicting if You'll Live to 100
MAR 16, 2021
A Blood Test for Predicting if You'll Live to 100
In 2012, a United Nations report estimated that there are over 316,000 people worldwide over the age of 100. What’ ...
MAR 18, 2021
Neuroscience
Pregnancy Alters the Stress Response in Surprising Ways
MAR 18, 2021
Pregnancy Alters the Stress Response in Surprising Ways
Researchers from Ohio State University have found that the stress response works in unexpected ways in pregnant mice. Th ...
MAY 03, 2021
Neuroscience
Researchers Use Live Human Neurons to Map How the Brain Works
MAY 03, 2021
Researchers Use Live Human Neurons to Map How the Brain Works
In a new study, researchers have identified previously unknown attributes of human neurons after being given rare access ...
MAY 10, 2021
Cell & Molecular Biology
Getting RNA-Based Medicine Past the Blood-Brain Barrier
MAY 10, 2021
Getting RNA-Based Medicine Past the Blood-Brain Barrier
RNA molecules serve several functions, one of which is to help the cell generate proteins from active genes. It also may ...
MAY 11, 2021
Neuroscience
People with Neurological Problems from COVID More Likely to Die in Hospital
MAY 11, 2021
People with Neurological Problems from COVID More Likely to Die in Hospital
Researchers from the University of Pittsburgh have found that patients with clinically diagnosed neurological symptoms l ...
MAY 23, 2021
Neuroscience
Study Links Alcohol Consumption to a Decline in Brain Health
MAY 23, 2021
Study Links Alcohol Consumption to a Decline in Brain Health
Thinking of cracking open a cold one this weekend? Researchers from the University of Oxford have identified a connectio ...
Loading Comments...